Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reconsolidation Therapy With Propranolol for Chronic Pain
NCT05085782Phase 2Completed
- Sponsor
- Université de Sherbrooke
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in chronic low back pain (CLBP), fibromyalgia (FM), sponsored by Université de Sherbrooke. Started Feb 2022; status: completed.
02
Drugs
propranolol
03
Conditions
chronic low back pain (CLBP)fibromyalgia (FM)
Beyond the preview
Go deeper on NCT05085782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05085782.